PSOH | Association Partnerships

Latest from PSOH

The Impact of CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma

March 30, 2021

The paradigm for management of relapsed myeloma is evolving rapidly with a plethora of treatment options based on results of clinical trials. One explosive area of scientific and clinical research is the investigation of chimeric antigen receptor T-cell therapy.

Targeted Oncology™ Announces the Addition of Pennsylvania Society of Oncology and Hematology to Its Strategic Alliance Partnership Program

October 13, 2020

Targeted Oncology, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, has added the Pennsylvania Society of Oncology and Hematology to its Strategic Alliance Partnership program.